Pascal and Francis Bibliographic Databases

Help

Search results

Your search

jo.\*:("Handbook of experimental pharmacology")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2412

  • Page / 97
Export

Selection :

  • and

Ceramide in Cystic FibrosisGRASSME, Heike; RIETHMÜLLER, Joachim; GULBINS, Erich et al.Handbook of experimental pharmacology. 2013, Vol 216, pp 265-274, issn 0171-2004, 10 p.Article

Sphingolipids and Inflammatory Diseases of the SkinKLEUSER, Burkhard; JAPTOK, Lukasz.Handbook of experimental pharmacology. 2013, Vol 216, pp 355-372, issn 0171-2004, 18 p.Article

Sphingolipids in Obesity, Type 2 Diabetes, and Metabolic DiseaseRUSSO, S. B; ROSS, J. S; COWART, L. A et al.Handbook of experimental pharmacology. 2013, Vol 216, pp 373-401, issn 0171-2004, 29 p.Article

Neuronal Forms of Gaucher DiseaseVITNER, Einat B; FUTERMAN, Anthony H.Handbook of experimental pharmacology. 2013, Vol 216, pp 405-419, issn 0171-2004, 15 p.Article

Sphingolipids in Psychiatric Disorders and Pain SyndromesMÜHLE, C; REICHEL, M; GULBINS, E et al.Handbook of experimental pharmacology. 2013, Vol 216, pp 431-456, issn 0171-2004, 26 p.Article

Sphingolipid Metabolism and Neutral SphingomyelinasesAIROLA, Michael V; HANNUN, Yusuf A.Handbook of experimental pharmacology. 2013, Vol 215, pp 57-76, issn 0171-2004, 20 p.Article

The Role of Ceramide-1-Phosphate in Biological FunctionsALEXIS HOEFERLIN, L; WIJESINGHE, Dayanjan S; CHALFANT, Charles E et al.Handbook of experimental pharmacology. 2013, Vol 215, pp 153-166, issn 0171-2004, 14 p.Article

The Therapeutic Potential of Nanoscale Sphingolipid TechnologiesHANKINS, Jody L; DOSHI, Ushma A; HAAKENSON, Jeremy K et al.Handbook of experimental pharmacology. 2013, Vol 215, pp 197-210, issn 0171-2004, 14 p.Article

Novel Chemotherapeutic Drugs in Sphingolipid Cancer ResearchCANALS, Daniel; HANNUN, Yusuf A.Handbook of experimental pharmacology. 2013, Vol 215, pp 211-238, issn 0171-2004, 28 p.Article

Circadian Clocks and MetabolismMARCHEVA, Biliana; RAMSEY, Kathryn M; PEEK, Clara B et al.Handbook of experimental pharmacology. 2013, Vol 217, pp 127-155, issn 0171-2004, 29 p.Article

Pharmacotherapy of pulmonary HypertensionHUMBERT, Marc; EVGENOV, Oleg V; STASCH, Johannes-Peter et al.Handbook of experimental pharmacology. 2013, Vol 218, issn 0171-2004, 560 p.Serial Issue

Anti-inflammatory and Immunosuppressive Agents in PAHMELOCHE, Jolyane; RENARD, Sébastien; PROVENCHER, Steeve et al.Handbook of experimental pharmacology. 2013, Vol 218, pp 437-476, issn 0171-2004, 40 p.Article

Muscarinic Receptor Pharmacology and Circuitry for the Modulation of CognitionBUBSER, Michael; BYUN, Nellie; WOOD, Michael R et al.Handbook of experimental pharmacology. 2012, Vol 208, pp 121-166, issn 0171-2004, 46 p.Article

Muscarinic Agonists and Antagonists: Effects on the Urinary BladderSELLERS, Donna J; CHESS-WILLIAMS, Russ.Handbook of experimental pharmacology. 2012, Vol 208, pp 375-400, issn 0171-2004, 26 p.Article

Appetite ControlJOST, Hans-Georg.Handbook of experimental pharmacology. 2012, Vol 209, issn 0171-2004, 481 p.Serial Issue

Neuropeptides Controlling Energy Balance: Orexins and NeuromedinsNIXON, Joshua P; KOTZ, Catherine M; NOVAK, Colleen M et al.Handbook of experimental pharmacology. 2012, Vol 209, pp 77-109, issn 0171-2004, 33 p.Article

Effects of Amylin on Eating and AdiposityALEXANDER LUTZ, Thomas.Handbook of experimental pharmacology. 2012, Vol 209, pp 231-250, issn 0171-2004, 20 p.Article

Reuptake Inhibitors of Dopamine, Noradrenaline, and SerotoninKINTSCHER, Ulrich.Handbook of experimental pharmacology. 2012, Vol 209, pp 339-347, issn 0171-2004, 9 p.Article

Appetite-Modifying Effects of Bombesin Receptor Subtype-3 AgonistsDEB MAJUMDAR, Ishita; CHRISTIAN WEBER, H.Handbook of experimental pharmacology. 2012, Vol 209, pp 405-432, issn 0171-2004, 28 p.Article

Heparin and Heparan Sulfate: Analyzing Structure and MicroheterogeneitySHRIVER, Zachary; CAPILA, Ishan; VENKATARAMAN, Ganesh et al.Handbook of experimental pharmacology. 2012, Vol 207, pp 159-176, issn 0171-2004, 18 p.Article

Neutralization of Heparin ActivityPAI, Menaka; CROWTHER, Mark A.Handbook of experimental pharmacology. 2012, Vol 207, pp 265-277, issn 0171-2004, 13 p.Article

Heparan Sulphate: A Heparin in MiniatureGALLAGHER, J. T.Handbook of experimental pharmacology. 2012, Vol 207, pp 347-360, issn 0171-2004, 14 p.Article

Heparin MimeticsCOOMBE, Deirdre R; KETT, Warren C.Handbook of experimental pharmacology. 2012, Vol 207, pp 361-383, issn 0171-2004, 23 p.Article

Antiplatelet AgentsGRESELE, Paolo; BORN, Gustav V.R; PATRONO, Carlo et al.Handbook of experimental pharmacology. 2012, Vol 210, issn 0171-2004, 625 p.Serial Issue

Nicotinic Receptors and Functional Regulation of GABA Cell Microcircuitry in Bipolar Disorder and SchizophreniaBENES, Francine M.Handbook of experimental pharmacology. 2012, Vol 213, pp 401-417, issn 0171-2004, 17 p.Article

  • Page / 97